Quantcast

Latest Sarcoma Stories

2008-08-12 12:00:34

NASHVILLE, Tenn., Aug. 12 /PRNewswire/ -- A drug widely used to treat high cholesterol is helping beat cancer. Lovastatin is part of a new cancer treatment that has arrested or eradicated tumors in more than 80% of initial patients. The first person treated with the investigative protocol in 2000 had stage 4 melanoma; he remains disease-free today. Lovastatin, the first of the statin group of lipid fighters, was introduced in 1980. Early studies revealed an unexpected side effect ---...

2008-07-16 03:00:00

By Guinee, Donald G Allen, Timothy Craig * Context.-Overwhelmingly, the most common neoplasm involving the pleura is metastatic carcinoma. In contrast, diffuse malignant mesothelioma occurs relatively rarely; however, it is nonetheless the most common neoplasm primary to the pleura. Metastatic carcinoma and diffuse malignant mesothelioma each have their own prognostic and therapeutic characteristics. Other primary pleural neoplasms occur uncommonly or rarely, with their own prognostic and...

2008-07-16 03:00:16

By Litzky, Leslie A * Context.-Sarcomatous pulmonary neoplasms are a rare and diagnostically challenging group of tumors. Primary pulmonary sarcomas must be distinguished from the more frequent occurrence of sarcoma metastatic to the lung, primary pulmonary sarcomatoid carcinoma, and diffuse malignant mesothelioma involving the lung. In current practice, the general availability of ancillary diagnostic techniques, such as immunohistochemistry and molecular analysis, can reliably classify...

2008-07-16 03:00:16

By Dishop, Megan K Kuruvilla, Supriya * Context.-Primary lung neoplasms are rare in children, but they comprise a broad and interesting spectrum of lesions, some of which are familiar from other tissue sites, and some of which are unique to the pediatric lung. Objective.-To determine the relative incidence of primary and metastatic lung tumors in children and adolescents through a single-institution case series, to compare these data to reports in the medical literature, to discuss the...

2008-07-14 00:00:10

NASHVILLE, Tenn., July 14 /PRNewswire/ -- A newly available treatment already has benefited several individuals with aggressive malignancies. Offered through NeoPlas Innovation, this regimen has arrested or eradicated tumors in more than 80% of initial patients. Director of Research Dr. Stephen Cantrell emphasized that human testing is in its early stages, but added, "These results have surprised us. This is far beyond what currently available standard treatments achieve." Melanoma, a...

2008-07-08 09:01:11

ImClone Systems has announced that a Phase II clinical trial of IMC-A12, the company's fully human, IgG1 anti-insulin-like growth factor-1 receptor monoclonal antibody, in adolescents and adult patients with several types of soft tissue sarcoma has opened for patient enrollment. This multinational Phase II study will evaluate the efficacy of IMC-A12 in adult and adolescent patients with several types of previously treated, advanced or metastatic soft tissue sarcoma, which were selected...

2008-07-07 09:01:02

ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that a Phase 2 clinical trial of IMC-A12, ImClone's fully human, IgG1 anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody, in adolescents and adult patients with several types of soft tissue sarcoma has opened for patient enrollment. "This Phase 2 study of IMC-A12 builds on a biological rationale that suggests that the...

2008-07-06 15:00:28

By Daniel Axelrod, The Times-Tribune, Scranton, Pa. Jul. 6--TOBYHANNA -- Fifteen-year-old Alexandria "Xandi" Robbins' 5-foot-7-inch frame dropped from 300 to 125 pounds in the 16 months before she died in September at her Tobyhanna home. Former Tobyhanna resident Thomas Abramouski, 16, now of Moscow, was so tired and weak he fainted into his father's arms in March 2007. Doctors gave him a prosthetic knee. A few months later, surgeons stopped the crippling pain of Thomas' friend and...

2008-06-25 12:03:12

Helicos BioSciences has entered into a scientific collaboration with the Children's Oncology Group in order to interrogate a wide spectrum of genomic variation within various sarcomas, an aggressive type of bone or soft tissue cancer usually found in children and young adults. The scientific collaboration is aimed at demonstrating the power and versatility of the Helicos true single molecule sequencing technology to measure the DNA sequence, methylation state, and mRNA expression levels of...

2008-06-05 03:00:07

By Edwards, Michael A Beatty, John S; Shah, Malay B; Bittner, James G IV To the Editor: Non-epithelial mesenchymal tumors, including gastrointestinal stromal tumors (GISTs) and smooth muscle tumors (SMTs), are rare and may occur in any part of the alimentary tract.1 GISTs originate from the interstitial cell of Cajal, an intestinal pacemaker cell, and represent 1 per cent to 3 per cent of all gastrointestinal malignant tumors. Approximately 5 per cent of GISTs occur in the colon and rectum...


Latest Sarcoma Reference Libraries

0_336928514f8c16d00d00e956be85245d
2011-02-17 15:06:48

Kaposi's sarcoma-associated herpesvirus (KSHV) one of seven currently known human cancer virus, is also the eighth human herpesvirus. Kaposi's sarcoma, caused by the virus, is common in AIDS patients, primary effusion lymphoma, and some types of multicentric Castelman's disease. Moritz Kaposi discovered the blood vessel tumor, in 1872, which would eventually be names Kaposi's sarcoma. It was originally though that KS was of Jewish and Mediterranean origins until it was found to be common...

More Articles (1 articles) »
Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related